Compile Data Set for Download or QSAR
Report error Found 45 Enz. Inhib. hit(s) with all data for entry = 11067
TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588519(US11542290, Compound MT-035)
Affinity DataIC50: 240nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588481(US11542290, Compound A-7)
Affinity DataIC50: 470nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoPurchaseSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588520(US11542290, Compound MT-037 | US11542290, Compound...)
Affinity DataIC50: 850nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588491(US11542290, Compound MT-009)
Affinity DataIC50: 860nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588490(US11542290, Compound MT-008)
Affinity DataIC50: 900nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588513(US11542290, Compound MT-030a)
Affinity DataIC50: 1.01E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM79181(cid_2913535 | TRIFLUOPERAZINE | SMR000059133 | MLS...)
Affinity DataIC50: 1.06E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM79181(cid_2913535 | TRIFLUOPERAZINE | SMR000059133 | MLS...)
Affinity DataIC50: 1.06E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM79181(cid_2913535 | TRIFLUOPERAZINE | SMR000059133 | MLS...)
Affinity DataIC50: 1.11E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588484(US11542290, Compound MT-002)
Affinity DataIC50: 1.41E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588512(US11542290, Compound MT-030)
Affinity DataIC50: 1.65E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588485(US11542290, Compound MT-003)
Affinity DataIC50: 1.73E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588508(US11542290, Compound MT-026)
Affinity DataIC50: 2.03E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588501(US11542290, Compound MT-019)
Affinity DataIC50: 2.83E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588515(US11542290, Compound MT-031a)
Affinity DataIC50: 2.97E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588489(US11542290, Compound MT-007)
Affinity DataIC50: 2.97E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588520(US11542290, Compound MT-037 | US11542290, Compound...)
Affinity DataIC50: 2.99E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588487(US11542290, Compound MT-005)
Affinity DataIC50: 3.17E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588522(US11542290, Compound MT-038)
Affinity DataIC50: 3.90E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588505(US11542290, Compound MT-023)
Affinity DataIC50: 3.96E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588518(US11542290, Compound MT-034)
Affinity DataIC50: 4.10E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588493(US11542290, Compound MT-011)
Affinity DataIC50: 4.47E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588510(US11542290, Compound MT-028)
Affinity DataIC50: 4.83E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588517(US11542290, Compound MT-033)
Affinity DataIC50: 4.99E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588494(US11542290, Compound MT-012)
Affinity DataIC50: 5.65E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588507(US11542290, Compound MT-025)
Affinity DataIC50: 6.70E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588506(US11542290, Compound MT-024)
Affinity DataIC50: 7.02E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588516(US11542290, Compound MT-032)
Affinity DataIC50: 7.43E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588498(US11542290, Compound MT-016)
Affinity DataIC50: 7.82E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588503(US11542290, Compound MT-021)
Affinity DataIC50: 8.13E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588514(US11542290, Compound MT-031)
Affinity DataIC50: 8.93E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588509(US11542290, Compound MT-027)
Affinity DataIC50: 9.03E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588496(US11542290, Compound MT-014)
Affinity DataIC50: 9.60E+3nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588502(US11542290, Compound MT-020)
Affinity DataIC50: 1.39E+4nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588511(US11542290, Compound MT-029)
Affinity DataIC50: 1.39E+4nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588504(US11542290, Compound MT-022)
Affinity DataIC50: 1.53E+4nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM50375645(CHEMBL219301 | US11542290, Compound A-3)
Affinity DataIC50: 2.41E+4nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588483(US11542290, Compound MT-001)
Affinity DataIC50: 3.21E+4nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588499(US11542290, Compound MT-017)
Affinity DataIC50: 5.51E+4nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588488(US11542290, Compound MT-006)
Affinity DataIC50: 7.58E+4nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588486(US11542290, Compound MT-004)
Affinity DataIC50: 9.49E+4nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588500(US11542290, Compound MT-018)
Affinity DataIC50: 1.00E+5nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588495(US11542290, Compound MT-013)
Affinity DataIC50: 1.00E+5nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588492(US11542290, Compound MT-010)
Affinity DataIC50: 1.00E+5nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCalmodulin-1(Human)
Camp4 Therapeutics

US Patent
LigandPNGBDBM588497(US11542290, Compound MT-015)
Affinity DataIC50: 1.00E+5nMAssay Description:The competition binding assay was performed in a 384-well plate format and in 20 μl reactions. Serial dilutions (0.001-100 μM) of a test co...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent